India Glycols Q1FY26: Revenue Up 7%, EBITDA Up 18%, PAT Up 21%; Restructuring Announced
The strong financial performance coupled with a major restructuring announcement is likely to have a significant impact on the company's stock price and future prospects.
The company reported strong financial results for Q1FY26, with significant growth in revenue, EBITDA, and PAT. The proposed restructuring is also presented as a strategic move to unlock value.
* India Glycols Limited (IGL) announced strong Q1FY26 results with gross revenue at ₹ 2,503 Cr, up 9.7% YoY. * Net revenue stood at ₹ 1,040 Cr, up 7.4% YoY. Bio Fuel increased by 45.4% to ₹ 348 Cr and PS up by 22.4% YoY to ₹ 342 Cr. * EBITDA increased by 17.7% to ₹ 151 Cr with EBITDA margin at 14.5% vs. 13.2% in Q1FY25. * PAT stood at ₹ 73 Cr, up by 21.3% with PAT margin at 7.0% as against 6.2% in Q1FY25. * Share of profit in JV increased by 73.7% YoY to ₹ 19 Cr from ₹ 11 Cr. * The company has fixed 12 August 2025 as the record date for the sub-division/split of equity shares. * Post record date, equity shares will be increased from 3,09,61,500 equity shares to 6,19,23,000 equity shares. * IGL is undergoing a restructuring involving the demerger of Potable Spirits & Bio-fuel and Bio-pharma businesses into separate entities: IGL Spirits Limited (ISL) and Ennature Bio Pharma Limited (EBL) respectively. * ISL shall issue 1 (One) Equity Share for every 1 (One) Equity Share of IGL held. * EBL shall issue 1 (One) Equity Share for every 3 (Three) Equity Shares of IGL held.
What to do with a filing like this
India Glycols Limited filed this with the NSE as a statutory disclosure, categorised under results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by India Glycols Limited. Read the original for the full detail.